Search results for "TRIGLYCERIDES"

showing 10 items of 301 documents

Dietary protein deficiency affects n-3 and n-6 polyunsaturated fatty acids hepatic storage and very low density lipoprotein transport in rats on diff…

1994

Fatty livers and the similarity between the skin lesions in kwashiorkor and those described in experimental essential fatty acid (EFA) deficiency have led to the hypothesis that protein and EFA deficiencies may both occur in chronic malnutrition. The relationship between serum very low density lipoprotein (VLDL) and hepatic lipid composition was studied after 28 d of protein depletion to determine the interactions between dietary protein levels and EFA availability. Rats were fed purified diets containing 20 or 2% casein and 5% fat as either soybean oil rich in EFA, or salmon oil rich in eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, or hydrogenated coconut, oil poor in EFA. Animal…

Malemedicine.medical_specialtyVery low-density lipoproteinfood.ingredientLow proteinDocosahexaenoic AcidsBiologyLipoproteins VLDLBiochemistrySoybean oilchemistry.chemical_compoundfoodEssential fatty acidInternal medicineCaseinFatty Acids Omega-6Protein DeficiencyFatty Acids Omega-3medicineAnimalsFood scienceRats WistarPhospholipidsTriglycerideschemistry.chemical_classificationFatty Acids EssentialOrganic Chemistryfood and beveragesFatty acidBiological TransportCell BiologyDietary FatsDietRatsEndocrinologychemistryEicosapentaenoic AcidLiverFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Arachidonic acidDietary ProteinsPolyunsaturated fatty acidLipids
researchProduct

White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial.

2013

Reduction of cardiovascular risk with high consumption of fish in diet is still a matter of debate, and concerns about heavy metal contamination have limited consumption of oily fish. We aimed to evaluate the effect of regular ingestion of white fish on cardiovascular risk factors in patients with metabolic syndrome.Multicenter randomized crossover clinical trial including 273 individuals with metabolic syndrome. An 8-week only-one dietary intervention: 100 g/d of white fish (Namibia hake) with advice on a healthy diet, compared with no fish or seafood with advice on a healthy diet. Outcomes were lipid profile, individual components of the metabolic syndrome, serum insulin concentrations, h…

Malemedicine.medical_specialtyWaistMeatEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyBlood Pressurelaw.inventionBody Mass Indexchemistry.chemical_compoundInsulin resistanceRandomized controlled triallawRisk FactorsInternal medicinemedicineOily fishAnimalsHumansInsulinTriglyceridesAgedMetabolic SyndromeNutrition and DieteticsTriglyceridemedicine.diagnostic_testbusiness.industryCholesterol HDLFatty AcidsFishesCholesterol LDLMiddle Agedmedicine.diseaseDietBlood pressureEndocrinologyC-Reactive ProteinTreatment OutcomechemistrySeafoodCardiovascular DiseasesFemaleMetabolic syndromeInsulin ResistanceWaist CircumferenceCardiology and Cardiovascular MedicineLipid profilebusinessNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Differences in clinical and biological characteristics and prevalence of chronic complications related to aging in patients with type 2 diabetes

2015

Type 2 diabetes mellitus (T2DM) is a chronic, highly prevalent disease that increases with age. Because of this, and due to its chronic complications, T2DM causes high human, social, and financial costs. In addition, the elderly population with T2DM has a marked clinical heterogeneity. Therefore, our main objective was to analyze the relationship of age with the clinical and biological manifestations of the disease and the prevalence of chronic complications in patients with T2DM.A cross-sectional study of a large population with T2DM (n=405) randomly selected from a Diabetes Unit and 2 health care centers (60%). The clinical, anthropometric, and biochemical variables of the subjects were c…

Malemedicine.medical_specialtyendocrine system diseasesCross-sectional studyBlood Pressure030209 endocrinology & metabolismDiseaseType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinePrevalencemedicineHumans030212 general & internal medicineTriglyceridesAgedMetabolic Syndromebusiness.industryAge Factorsnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseSurgeryCross-Sectional StudiesDiabetes Mellitus Type 2FemaleWaist CircumferenceMetabolic syndromebusinessPolyneuropathyKidney diseaseEndocrinología y Nutrición (English Edition)
researchProduct

Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholest…

2014

Abstract Purpose The effects of Portulaca oleracea ( Po ) lyophilized aqueous extract were determined on the serum high-density lipoproteins (HDL 2 and HDL 3 ) amounts and composition, as well as on lecithin: cholesterol acyltansferase (LCAT) activity. Methods Male Wistar rats ( n  = 12) were fed on 1% cholesterol-enriched diet for 10 days. After this phase, hypercholesterolemic rats (HC) were divided into two groups fed the same diet supplemented or not with Portulaca oleracea ( Po -HC) (0.5%) for four weeks. Results Serum total cholesterol (TC) and triacylglycerols (TG), and liver TG values were respectively 1.6-, 1.8-, and 1.6-fold lower in Po -HC than in HC group. Cholesterol concentrat…

Malemedicine.medical_specialtyfood.ingredientHypercholesterolemiaPharmaceutical SciencePortulacaPortulacaLecithinCholesterol DietaryPhosphatidylcholine-Sterol O-Acyltransferasechemistry.chemical_compoundfoodInternal medicineDrug DiscoverymedicineAnimalsRats WistarTriglyceridesHypolipidemic AgentsPharmacologychemistry.chemical_classificationHypertriglyceridemiaChromatographybiologyCholesterolPlant ExtractsReverse cholesterol transportbiology.organism_classificationPlant LeavesEnzymeEndocrinologyCholesterolComplementary and alternative medicinechemistryLiverLecithin—cholesterol acyltransferasebiology.proteinMolecular Medicinelipids (amino acids peptides and proteins)Composition (visual arts)Acyl groupPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Cacao extract enriched in polyphenols prevents endocrine-metabolic disturbances in a rat model of prediabetes triggered by a sucrose rich diet.

2019

Cocoa extracts rich in polyphenols are used as potential agent for treating diabetes. Cocoa polyphenols have been proved to ameliorate important hallmarks of type-2 diabetes (T2D). They can regulate glucose levels by increasing insulin secretion, promoting β-cell proliferation and a reduction of insulin resistance. In addition, epidemiological evidence indicates that consumption of flavonoid decreases the incidence of T2D.T2D is preceded by a prediabetic state in which the endocrine-metabolic changes described in T2D are already present. Since epidemiological evidence indicates that consumption of flavonoid decreases its incidence, we evaluated possible preventive effects of polyphenol-enri…

Malemedicine.medical_specialtymedicine.disease_causePrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDietary SucroseInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHumansPrediabetesTriglycerides030304 developmental biologyPharmacology0303 health sciencesCacaoGlycogenPlant ExtractsCocoa ExtractHypertriglyceridemiafood and beveragesPolyphenolsGlutathionemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Liver030220 oncology & carcinogenesisInsulin ResistanceOxidative stressJournal of ethnopharmacology
researchProduct

Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.

1995

A randomized double-blind study was carried out with gemfibrozil (600 mg b.i.d.) vs placebo in 20 patients (twelve males and eight females, age 52 +/- 3 years, BMI 24.2 +/- 0.4) suffering from primary hypertriglyceridemia (Fredrickson's type IV). Each group was treated for a 12 week period with gemfibrozil (n = 10) or placebo (n = 10) patients) in a double-blind fashion. Total cholesterol, HDL-cholesterol (HDL-C) and its subfractions (HDL2-C and HDL3-C), blood glucose, Apolipoproteins A1 and B, fibrinogen, plasminogen, factor VII, t-PA:Ag and PAI activity pre- and post-venous occlusion (VO) were determined. In the gemfibrozil-treated group a significant decrease of total cholesterol and tri…

Malemedicine.medical_specialtymedicine.medical_treatmentLipoproteinsFibrinogenchemistry.chemical_compoundDouble-Blind MethodInternal medicineFibrinolysismedicineGemfibrozilHumansTriglyceridesApolipoproteins BHypertriglyceridemiaTriglycerideApolipoprotein A-Ibusiness.industryCholesterolFibrinolysisHypertriglyceridemiaReverse cholesterol transportCholesterol HDLFibrinogenPlasminogenHematologyGeneral MedicineFactor VIIMiddle Agedmedicine.diseaseEndocrinologyCholesterolchemistryTissue Plasminogen Activatorlipids (amino acids peptides and proteins)FemaleGemfibrozilbusinessLipoproteinmedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

2018

Background and objective: Obstructive sleep apnoea (OSA) and dyslipidaemia are independent risk factors for cardiovascular disease. This study investigates the association between OSA and plasma lipid concentrations in patients enrolled in the European Sleep Apnea Database (ESADA) cohort. Methods: The cross-sectional analysis included 8592 patients without physician-diagnosed hyperlipidaemia or reported intake of a lipid-lowering drug (age 50.1 ± 12.7 years, 69.1% male, BMI: 30.8 ± 6.6 kg/m2, mean apnoea–hypopnoea index (AHI): 25.7 ± 25.9 events/h). The independent relationship between measures of OSA (AHI, oxygen desaturation index (ODI), mean and lowest oxygen saturation) and lipid profil…

MaleobesityDatabases Factualcholesterol dyslipidemia hypoxia obesity sleep apnoeaGastroenterologyCohort Studieschemistry.chemical_compound0302 clinical medicineRisk FactorsHypolipidemic AgentsOxygen saturation (medicine)Sleep Apnea Obstructivemedicine.diagnostic_testSleep apneaMiddle AgedEuropeQuartileCardiovascular DiseasesCohortFemalelipids (amino acids peptides and proteins)AdultPulmonary and Respiratory Medicinemedicine.medical_specialtySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesInternal medicinemedicineHumansTriglyceridesDyslipidemiashypoxiaCholesterolbusiness.industryCholesterol HDLdyslipidemiacholesterolCholesterol LDLta3121medicine.diseaseObesitynervous system diseasesrespiratory tract diseasesCross-Sectional Studies030228 respiratory systemchemistryLipid profilebusinesssleep apnoea030217 neurology & neurosurgeryDyslipidemiaRespirology
researchProduct

Isotemporal substitution of inactive time with physical activity and time in bed: cross-sectional associations with cardiometabolic health in the PRE…

2019

Background: This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Methods: This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m(2)) from the PREDIMED-Plus study (http://www.predimedplus.com/). All participants had >= 3…

MalesueñoTime FactorshumanosMedicine (miscellaneous)ejercicio físicoType 2 diabetes030204 cardiovascular system & hematologyLogistic regressiontriglicéridosIsotemporal substitutionchemistry.chemical_compound0302 clinical medicineRisk FactorsAccelerometryInactive timeModerate-to-vigorous physical activityModerate to vigorous physical activityTime in bedlcsh:RC620-627mediana edadAdiposityCardiometabolic risk Inactive time Isotemporal substitution Light physical activity Moderate to vigorous physical activity Time in bedMetabolic SyndromeancianoNutrition and Dieteticslcsh:Public aspects of medicinecolesterolMiddle AgedLight physical activity3. Good healthlcsh:Nutritional diseases. Deficiency diseasesCholesterolCardiovascular diseasesFemaleadiposidadWaist Circumferencemedicine.medical_specialtyWaistRestPhysical Therapy Sports Therapy and RehabilitationClinical nutrition03 medical and health sciencesfactores de tiempo:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Internal medicineacelerometríaDiabetes Mellitusmedicinefactores de riesgoHumansObesityobesidadExerciseTriglyceridesAgedRetrospective Studiesperímetro abdominalMalalties cardiovascularsbusiness.industryResearchestudios retrospectivosCholesterol HDLlcsh:RA1-1270030229 sport sciencesPhysical fitnessmedicine.diseaseObesityUnited KingdomCardiometabolic riskCross-Sectional StudiesBlood pressureDiabetes Mellitus Type 2chemistryDescansGlycated hemoglobinSedentary BehaviorMetabolic syndromeSleepbusinessestudios transversalesCondició físicaInternational Journal of Behavioral Nutrition and Physical Activity
researchProduct

Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats

2020

Understanding the importance of the gut microbiota (GM) in non-alcoholic fatty liver disease (NAFLD) has raised the hope for therapeutic microbes. We have shown that high hepatic fat content associated with low abundance of Faecalibacterium prausnitzii in humans and, further, the administration of F. prausnitzii prevented NAFLD in mice. Here, we aimed at targeting F. prausnitzii by prebiotic xylo-oligosaccharides (XOS) to treat NAFLD. First, the effect of XOS on F. prausnitzii growth was assessed in vitro. Then, XOS was supplemented or not with high (HFD, 60% of energy from fat) or low (LFD) fat diet for 12 weeks in Wistar rats (n = 10/group). XOS increased F. prausnitzii growth, having onl…

MalesuolistomikrobistoPROGRESSIONBIFIDOBACTERIASTEATOHEPATITISNon-alcoholic Fatty Liver DiseaseCecumDiet Fat-RestrictedaineenvaihduntaFatty Acidsrasvamaksafood and beveragesmitochondriaLiverprebioticBody CompositionBIOPSIESFemaleOxidation-Reductionlcsh:Nutrition. Foods and food supplymitokondriotGlucuronateslcsh:TX341-641Diet High-Fatdigestive systemArticleDYSBIOSISprebiootitINFLAMMATIONLIVER-DISEASEINTESTINAL MICROBIOTAoligosaccharidesoligosakkariditAnimalsRats WistarTriglyceridesfatty livergut microbiotaFaecalibacterium prausnitziinutritional and metabolic diseasesLipid MetabolismGastrointestinal MicrobiomeRatsFAECALIBACTERIUM-PRAUSNITZIIGlucosePrebiotics416 Food Scienceaineenvaihduntatuotteet3111 BiomedicineEnergy IntakeEnergy MetabolismmetabolismNutrients
researchProduct

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

2014

Item does not contain fulltext Plasma triglyceride concentration is a biomarker for circulating triglyceride-rich lipoproteins and their metabolic remnants. Common mild-to-moderate hypertriglyceridaemia is typically multigenic, and results from the cumulative burden of common and rare variants in more than 30 genes, as quantified by genetic risk scores. Rare autosomal recessive monogenic hypertriglyceridaemia can result from large-effect mutations in six different genes. Hypertriglyceridaemia is exacerbated by non-genetic factors. On the basis of recent genetic data, we redefine the disorder into two states: severe (triglyceride concentration >10 mmol/L), which is more likely to have a mono…

Multifactorial InheritanceSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Genome-wide association studyDisease030204 cardiovascular system & hematologyISCHEMIC-HEART-DISEASEBioinformaticshypertriglyceridaemia0302 clinical medicineEndocrinologyGENERAL-POPULATIONHypertriglyceridemiatreatmentmedicine.diagnostic_testREMNANT CHOLESTEROLCombined Modality Therapy3. Good healthLIPASE DEFICIENCYdiagnosiPLASMA TRIGLYCERIDESDENSITY-LIPOPROTEIN CHOLESTEROLCARDIOVASCULAR-DISEASEPractice Guidelines as TopicBiomarker (medicine)Multifactorial Inheritancemedicine.medical_specialty030209 endocrinology & metabolismHealth PromotionArticle03 medical and health sciencesPharmacotherapyInternal medicineInternal MedicinemedicineAnimalsHumansHOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAGenetic Predisposition to DiseaseAlleleGENOME-WIDE ASSOCIATIONLife Stylehypertriglyceridaemia; diagnosis; treatmentTriglyceridesGenetic testingbusiness.industryHypertriglyceridemianutritional and metabolic diseasesmedicine.diseaseEndocrinologyNONFASTING TRIGLYCERIDESbusinessBiomarkersThe lancet. Diabetesendocrinology
researchProduct